Search Results 901-910 of 17381 for alopecia
Failure to have fully recovered (ie, ≤ Grade 1 toxicity) from the effects of prior chemotherapy (except for alopecia) regardless of the interval since last ...
... . ART-20051269. Home; Subscription Confirmation. Final days of 5X Challenge! 5X My Gift! The challenge ends 10/10. Your gift today can have 5X the ...
Home-based pulmonary rehabilitation program elements. Based on Respiratory Care 2018.
... . IMG-20451722. Home; cc-amber-liquor-rocks_thumbnail. 5X Challenge is here! 5X My Gift! Your gift today can have 5X the impact on AI research and ...
Toxicities of prior therapy (excepting alopecia) should be resolved to less than or equal to grade 1 as per CTCAE v 4.0; Adequately controlled blood pressure ...
with ongoing alopecia of any grade will be eligible; Patient must have a life expectancy of >= 3 months, as estimated by the treating oncologist; Patient must ...
Persistent toxicities (≥ CTCAE Grade 2), with the exception of alopecia, caused by previous cancer therapy. Resting ECG with QTc > 470msec on 2 or more ...
... alopecia) and/or in whom ≥ 25 percent (%) of the bone marrow was irradiated. Patients who have a previous or concurrent cancer that is distinct in primary ...
Any unrecovered toxicity reactions of CTCAE version 4.03 ≥ grade 1 caused by any previous therapy (excluding alopecia and neurotoxicity ≤ grade 2). QTcF ...
Allergic and immunologic disorders are very common but some are very poorly understood. Numerous studies of the epidemiology, characteristics, diagnosis and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.